Is SiriusPoint (SPNT) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy SiriusPoint (SPNT) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
SiriusPoint Q2 Earnings Call Highlights
SiriusPoint NYSE: SPNT reported second-quarter underwriting profitability and book value growth as the specialty insurer continued to shift capital toward insurance lines it views as offering stronger risk-adjusted returns.
SiriusPoint Ltd. (SPNT) Q2 2026 Earnings Call Transcript
SiriusPoint Ltd. (SPNT) Q2 2026 Earnings Call Transcript
SiriusPoint (SPNT) Q2 Earnings Surpass Estimates
SiriusPoint (SPNT) came out with quarterly earnings of $0.67 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.66 per share a year ago.
Are Investors Undervaluing SiriusPoint (SPNT) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
SiriusPoint Ltd. (SPNT) Soars to 52-Week High, Time to Cash Out?
SiriusPoint (SPNT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
SiriusPoint: The Turnaround Is Over, But The Valuation Hasn't Caught Up
SiriusPoint has evolved from a turnaround story into a disciplined specialty insurer with a significantly lower-risk underwriting profile. Continued reductions in catastrophe exposure are making earnings more durable rather than simply boosting one quarter's results. Capital allocation has shifted from balance sheet repair toward buybacks, preferred share redemptions, and long-term shareholder value creation.
SiriusPoint Ltd. (SPNT) Shareholder/Analyst Call Prepared Remarks Transcript
SiriusPoint Ltd. (SPNT) Shareholder/Analyst Call Prepared Remarks Transcript
SiriusPoint Q1 Earnings Call Highlights
SiriusPoint NYSE: SPNT reported a strong start to 2026, with management pointing to improved underwriting profitability, lower catastrophe volatility and continued capital returns during the company's first-quarter earnings call.
SiriusPoint Ltd. (SPNT) Q1 2026 Earnings Call Transcript
SiriusPoint Ltd. (SPNT) Q1 2026 Earnings Call Transcript
SiriusPoint (SPNT) Q1 Earnings Beat Estimates
SiriusPoint (SPNT) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.49 per share a year ago.
